Company / PP&E per Share
Edgewise Therapeutics, Inc. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.08
FY2025
5-year range
$0.02 / $0.16
FY2021-FY2025
Trend
-26.0%
vs FY2024
Sector context
#106 of 191
Health Care
What the data says
At $0.08, Edgewise Therapeutics, Inc.'s pp&e per share ranks #106 of 191 in the Health Care sector. Declined from $0.16 to $0.08 over the past 2 years.
Based on SEC 10-K filings.
0.08 in FY2025 with a 5-year CAGR of -35.8%.
Declined from $0.16 to $0.08 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -21.8%
- 5-Year CAGR
- -35.8%
- 10-Year CAGR
- -
Sector benchmark
#106 of 191 in Health CareTop 55% of 191This company $0.08 Sector average $18.90
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 26.0% year-over-year.
- Ranks #106 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
- Lowest pp&e per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.08 | -26.0% |
| FY2024 | $0.10 | -37.3% |
| FY2023 | $0.16 | +2.9% |
| FY2022 | $0.16 | +555.1% |
| FY2021 | $0.02 | -96.5% |
| FY2020 | $0.70 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026